Contract development and manufacturing organisation (CDMO), Biodeal Pharmaceuticals is looking to expand its injectable ...

India’s effort to shield domestic manufacturers from low-cost Chinese imports has yet to deliver the desired gains. Speaking ...

BioNTech's experimental mRNA cancer immunotherapy BNT113 did not meet its primary goal in a head and neck cancer trial, ...

Johnson & Johnson's Q3 earnings exceed expectations, driven by pharmaceutical sales but impacted by geopolitical issues and a sluggish medical devices market. Discover the company's strategies and ...

Roche has entered a significant licensing deal with Rona Therapeutics for an obesity drug, marking its entry into a ...

Bengaluru-based Peptris Technologies secures ₹86 crore RDI support for the preclinical development of innovative ...

Zydus Lifesciences announces that the FDA has accepted the BLA for FYB206, a biosimilar to Keytruda. As the patent expiration ...

NuSynth Technologies, a Bengaluru-based startup, has raised ₹36.5 crore in seed funding to develop an AI-driven chemical ...

Teva Pharmaceuticals has gained FDA approval for Weltruza, a monthly injectable treatment for schizophrenia, aiming to ...

The Supreme Court of India has called for extensive drug price regulation beyond just cancer medications, questioning high ...

Syndax Pharmaceuticals has announced the cessation of its treatment for idiopathic pulmonary fibrosis after a mid-stage trial ...

With its CNS pipeline nearing key clinical milestones,Suven Life Sciences is looking to tap a potential $100-billion global ...